Back to search

Article

Targeted fusion of Antibody-Secreting Cells: unlocking monoclonal antibody production with hybridoma technology

2025-03-19

Abstract excerpt

Monoclonal antibodies (mAbs) produced by hybridoma technology have extensively proved their value for therapeutic, diagnostic, and biomedical research applications, despite the reported low fusion yields between short-lived B cells and immortal myeloma cells. To improve the efficiency of this process and accelerate the development of new mAbs, we characterized and isolated antibody-secreting cells (ASCs) from the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ef8ab16-6984-5cfb-aaf7-ac504bab804c
DOI
10.1101/2025.03.19.644155
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted fusion of Antibody-Secreting Cells: unlocking monoclonal antibody production with hybridoma technologyDOI 10.1101/2025.03.19.644155
Select a neighboring publication to make it the new centre.